Small Compound Customization for Neurological Research
Thanks to the development of high throughput screening and advancement in the molecular biology techniques, more than 1100 small molecules are under investigation or were rejected in clinical trials for neurological diseases. Small molecules have been evolved as a potential tool to develop novel and effective therapeutics for neurological disorders.
Small molecules are able to modulate the activity of molecular targets that are involved in disease pathology. They have the potential to affect the neurological disease condition. For instance, some small molecules have been employed as therapeutics for Alzheimer's disease.
Creative Biolabs has developed a range of small molecules and provided small molecule customization and screening services. Our small molecules include activators, inhibitors, or RNA modulators that can be utilized to study the interaction and relation between various targets involved in neurological disease. These molecule targets can be enzymes, receptors, regulatory proteins, DNA, mRNA, antisense RNA, etc.
Signifying our commitment to partner with your teams to seek out discoveries, bringing you new choices for neurological research.